Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 USD | -3.56% | -10.24% | -31.18% |
Sales 2024 * | 219M 300M | Sales 2025 * | 225M 308M | Capitalization | 144M 197M |
---|---|---|---|---|---|
Net income 2024 * | 10M 13.68M | Net income 2025 * | 15M 20.52M | EV / Sales 2024 * | 0.66 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.64 x |
P/E ratio 2024 * |
12.3
x | P/E ratio 2025 * |
12.3
x | Employees | 185 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.6% |
Latest transcript on Puma Biotechnology, Inc.
1 day | -3.56% | ||
1 week | -10.24% | ||
Current month | -22.60% | ||
1 month | -31.81% | ||
3 months | -36.53% | ||
6 months | -24.17% | ||
Current year | -31.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-20 | 2.98 | -3.56% | 372,674 |
24-06-18 | 3.09 | -3.44% | 352,899 |
24-06-17 | 3.2 | +2.89% | 193,082 |
24-06-14 | 3.11 | -6.33% | 214,217 |
24-06-13 | 3.32 | -7.65% | 570,138 |
Delayed Quote Nasdaq, June 20, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.18% | 149M | |
+35.14% | 51.07B | |
-7.43% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+11.63% | 26.35B | |
-17.77% | 19.46B | |
+40.52% | 13.58B | |
+30.70% | 12.46B | |
-3.41% | 11.75B |
- Stock Market
- Equities
- PBYI Stock